Background The 'years of potential life lost' (YPLL) is a public health measure in widespread use. However, the index does not apply to the comparisons between different populations or across different time periods. It also has the limit of being crosssectional in nature, quantifying current burden but not future impact on society. Methods A new years-lost index is proposed-the 'cumulative rate of potential life lost' (CRPLL). It is a simple combination of the 'cumulative rate' (CR) and the YPLL. Vital statistics in Taiwan are used for demonstration and comparison of the new index with existing health-status measures.
population'. Also, the resulting age-standardized indices of potential life lost are not easily interpretable by themselves.
Another problem with the YPLL index is that it quantifies the cross-sectional (current) but not the prospective (future) impacts on society. It should be noted that the deaths in a crosssectional table have already taken place and are no longer preventable. 4 Therefore, when setting health goals for preventing and controlling diseases, it seems more pertinent to consider the future impact rather than the current burden. 4 In this paper, we propose a new years-lost index, namely the 'cumulative rate of potential life lost' (CRPLL). It is in fact a very simple index-a simple marriage of the 'cumulative rate' (CR) 5 and the YPLL. Yet, it serves the purpose of between-group comparison. It can also be considered a projection of future impact under the assumption that the age-specific mortality rates in the current year prevail.
The author uses vital statistics in Taiwan for demonstration and compares the new index with existing health-status measures.
The Cumulative Rate of Potential Life Lost (CRPLL)
We use mortality data of pneumonia and suidde in Taiwan (including the Kinma area), 1995, for the demonstration of the new index. Table 1 presents the death counts, population numbers, and mortalities in 5-year age groups. We assume the deaths, on average, occur at the mid-points of the intervals. And for the last interval (age *85), we assume an exponential decay. This is of course a very rough approximation, especially in the younger and the older age groups. For refinement one should turn to a more refined age grouping. We stop short of doing so in this paper since the principle remains the same. We also assume the upper age limit of the potential life lost to be 75, though the methodology can easily be modified for other cutoffs.
The proposed CRPLL is simply a cumulative rate with the 'weight' taken, in addition to the usual interval length, as the average years lost of a death occurring in each age group. Given the assumptions presented above, the average lost years in each age group i (denoted as /,) can be calculated as /,-= 75 -(5i -2.5), for / «£15. And for i >15, /, = 0. The CRPLL is defined through the following equation:
where the n f is the interval length of each age group and the m i is the age-spedfic mortality of the cause under concern.
For the above example of death from pneumonia, the CRPLL is calculated as 0.0961. And for suidde, it is 0.1505. Note that they take the unit of 'year 1 . However, for ease of presentation and interpretation, we change their units into 'day' (CRPLL = 35.1 days for pneumonia death and 55.0 days for suidde).
It is of interest to note that the above-defined CRPLL has an intuitive appeal when applied to a rare cause of death. The appendix shows that it can be interpreted as the expected years (days) of potential life lost due to the cause under concern (e.g. pneumonia and/or suidde) during a subject's lifetime, if he/she does not succumb to other competing causes of death.
The formula for the confidence intervals (CI) of the CRPLL can be derived easily which takes a very simple form:
where the p i is the population number of the age group ;. For the example of pneumonia death, the 95% CI of the CRPLL are calculated as 32.8, 37.5 (days). And for suidde, the 95% CI are 52.0, 57.9 (days).
Comparison with Other Health-status Measures
In this section, we compare the newly proposed CRPLL with some existing health-status measures, namely, the crude rate, the 'ASR' (age-standardized rate), 5 3 and the T.YPLL' (lifetime years of potential life lost). 4 The formulae for these indices are shown in Table 2 . It can be seen that all these indices are similar in form -they either take average or sum the age-spedfic mortalities (the w,-'s) of the population under study. The differences lie in the 'weights' being used. And this greatly determines the properties of the various indices. First, we see that the weights in calculating the crude rate, the YPLL, the YPLL per death, and the RPLL indices involve the age structure of the population under study (p,'s). Thus they are, as is already well known, crude measures unsuitable for between-group comparisons. The SRPLL is a standardized index like the ASR. They circumvent the problem of disparate population structures by introducing the 'Kj (standard population structure) as the basis of comparison. As has been pointed out however, the choice of such a standard may sometimes present a problem. By contrast, we see that the newly proposed CRPLL does not have this kind of problem. Its weight (/,• • ttj) does not involve the population under study or any other standard populations at all. Therefore, the CRPLL can legitimately be used to compare the impact of disease on different countries.
Second, we see that the weights of the various years-lost indices all involve the /,-, while the crude rate, the ASR, the CR, and the life table risk don't. The /,-, the average years lost of a death occurring in each age group, can be viewed as a value judgment imposed on each death. It reflects, in some sense, consequent social, family and economic burdens. Without it, the impact of a death will be the same irrespective of the age.
Third, we note that the interpretation of the CRPLL as the expected years of potential life lost during a subject's lifetime is similar to the well-known link between the CR and the lifetime disease probability. 5 They both reflect the projected risk an individual will have as he/she progresses through each age. However, the CR weighs the risk according to the amount of time spent in each age category (the n t ), whereas the CRPLL weighs the cumulative risk additionally with value judgment. Consequently, these two indices have different implications. From Table 2 , we see that the lifetime risk of pneumonia death in Taiwan is 0.0834 (CR = 0.0834), and it causes, on average, 35.1 (CRPLL = 35.1) days of potential life lost. As for suicide, we see that its lifetime risk (CR = 0.0122) is lower. Yet, it causes more potential life lost (CRPLL = 55.0 days) during a subject's lifetime.
Fourth, it is also of interest to compare the CRPLL with the LYPLL. 4 The LYPLL is a projected risk as well. However, the index is developed using the life table methodology (it involves the 'y(, the person-year in age group i of a life-table population). A life table explicitly assumes the presence of competing Table 3 The properties of the various health-status measures deaths. Thereby the loss measured by the LYPLL is the interplay of the cause of death under study and the competing deaths. By contrast, the CRPLL in this paper quantifies specifically the pure effect from the cause of death under concern. Just as the CR can be called a 'conditional risk' and a life-table risk, an 'unconditional risk', we may refer to the CRPLL as the 'conditional' years-lost index and the LYPLL, a YPLL of 'unconditional' type.
Finally, we note that the CRPLL, though it is a population summary index, is best understood at the individual level-a property also shared by the CR, the life-table risk, or the LYPLL. These indices reflect, from different perspectives, the lifetime history of an average subject in the population. This is in sharp contrast to the traditional YPLL index which, though it quantifies succinctly the burden of disease for the entire population, doesn't by any means possess an individual-level interpretation by itself. The properties of these various health-status measures are summarized in Table 3 .
Discussion
In this paper, we see that the proposed CRPLL has several desirable properties, rendering it a promising alternative for quantifying health status. It nicely condenses the whole table of age-specific mortality into a single but meaningful value-the expected year of potential life lost during a subject's lifetime. This valuable information is not readily discernible from a simple inspection of the mortality table per se. However, one should note that any index derived from condensation or summarization can mask important features of the data. For an aetiologic investigation, we believe that comparisons should still be based primarily on the table of age-specific rates rather than on a summary of it.
Secondly, it should be pointed out that the CRPLL is based on 'cross-sectional' but not 'longitudinal' data. The situation is just like the case of cumulative risk or life expectancy. All of them rely on the same assumption, i.e. each subject in the population will be subject throughout his or her life to the same agespecific mortality rates prevailing in the current year. Clearly, this is a bold assumption. In previous papers, the age-periodcohort (APC) modelling technique has been adopted to obtain the cohort-specific lifetime risk 7 and the cohort-specific life expectancy 8 from cross-sectional data. The same technique can also be applied to the present context. However, such modelling is technically involved and is beyond the scope of this paper. At present, it is advised that we interpret CRPLL with due caution as with lifetime risk and life expectancy. Finally, the CRPLL, being an index of the lost years due to death, is a measure of disease burden on society. However, a disease or an illness can exert its impact before death, by causing disability or jeopardizing quality of life, etc. Recently, there have been considerable efforts directed toward combining the two dimension of morbidity and mortality into a single index for disease burden (for example, the QALY and the DALY). 9 It is possible that the concept of cumulative rates may shed new light on the problem of constructing composite burden-of-disease indicators as well.
